Numans Health Food Holdings Company Limited stock analysis
Want to see HK:2530 full AI Analyst Report?
Numans Health Food Holdings Company Limited (2530) Stock Price & Analysis
2530 Stock Chart & Stats
- Day’s Range
- HKD 0.67 - HKD 0.68
- 52-Week Range
- HKD 0.45 - HKD 0.83
- Previous Close
- HKD 0.67
- Volume
- N/A
- Average Volume (3M)
- 427.47K
- Market Cap
- HKD 665.00M
- Enterprise Value
- HKD 252.15M
- Total Cash (Recent Filing)
- HKD 444.41M
- Total Debt (Recent Filing)
- HKD 4.99M
- Price to Earnings (P/E)
- 7.4
- Beta
- 0.13
- Next Earnings
- Mar 19, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jun 17, 2026
- Dividend Yield
- 3.68%
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet
Extremely low leverage and a substantial equity base reduce solvency risk and preserve financial flexibility. This gives the company greater capacity to withstand weak trading conditions, maintain operations, and fund strategic needs without relying heavily on external borrowing.
Healthy Cash Conversion
Cash generation remained closely aligned with reported earnings despite the decline in profitability, indicating that earnings were supported by cash rather than weak conversion. This provides a durable financial cushion and supports continued reinvestment or shareholder distributions.
High Gross Margin
The high gross margin indicates that the underlying product economics retain meaningful value capture even after the recent downturn. This margin buffer can help the company absorb weaker volumes and, if revenue stabilizes, provides scope for operating profitability to recover.
Bears Say
Sharp Revenue Contraction
A steep annual revenue decline signals a material deterioration in demand or business momentum, rather than normal quarter-to-quarter volatility. Unless sales recover, the smaller revenue base can reduce operating leverage and limit the company’s ability to rebuild earnings over coming periods.
Severe Margin Compression
The collapse in net margin shows that the revenue slowdown translated into a disproportionate loss of earnings power. Persistently thin profitability would leave less capacity for investment, dividends, and resilience, while making future results more sensitive to changes in operating performance.
Declining Free Cash Flow
Although cash conversion remained healthy, the substantial decline in free cash flow indicates weakening underlying financial momentum. Continued deterioration could reduce internally generated funding for growth and distributions, making the balance sheet’s strength less effective as an earnings substitute.
Numans Health Food Holdings Company Limited News
Numans Health Food Signals Higher Profit on Lower Revenue in Supplemental Alert
Numans Health Food Holdings Company Limited ( ($HK:2530) ) has provided an announcement. Numans Health Food Holdings Company Limited has issued a supplemental positive profit alert, indicating that while revenue
2530 FAQ
What was Numans Health Food Holdings Company Limited’s price range in the past 12 months?
What is Numans Health Food Holdings Company Limited’s market cap?
When is Numans Health Food Holdings Company Limited’s upcoming earnings report date?
How were Numans Health Food Holdings Company Limited’s earnings last quarter?
Is Numans Health Food Holdings Company Limited overvalued?
Does Numans Health Food Holdings Company Limited pay dividends?
What is Numans Health Food Holdings Company Limited’s EPS estimate?
How many shares outstanding does Numans Health Food Holdings Company Limited have?
What happened to Numans Health Food Holdings Company Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Numans Health Food Holdings Company Limited?
What is the TipRanks Smart Score and how is it calculated?
Numans Health Food Holdings Company Limited Stock Smart Score
Company Description
Numans Health Food Holdings Company Limited
Numans Health Food Holdings Company Limited focuses on the marketing, sale, and distribution of its Nemans-branded nutritional supplements across the People's Republic of China. Their extensive product range features algal oil docosahexaenoic acid (DHA), which supports brain and eye development in infants and children, and helps alleviate forgetfulness, anxiety, and postpartum depression in mothers. The company also offers probiotics, including solid drinks and lactic acid bacteria powders, to improve digestion and boost immunity for all ages. Other offerings include various vitamin and multi-nutrient products specifically formulated for pregnant women, infants, and children, as well as algal calcium and milk powders for diverse age groups. These products are distributed to consumers through both online platforms and traditional retail outlets. Established in Shanghai in 2002, Numans is a wholly-owned subsidiary of Far-East Fortune Management (China) Co., Ltd.
- Sector
- General
- Industry
- Packaged Foods
- CEO
- Ping Wang
- Employees
- 50
- Website
- www.numans.cc
- Address
- CN
Numans Health Food Holdings Company Limited (2530) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 5 | 9 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 6 | 0 | 6 |







